Supriya Life receives European drug body’s acclaim for antihistamine drug

Supriya Life receives European drug body’s acclaim for antihistamine drug

by admin- Thursday, September 29th, 2022 03:42:23 PM

Supriya Lifescience introduced that, The European Directorate for the Quality of Medicines and HealthCare (EDQM) has granted Certification of Suitability (CEP) for Diphenhydramine Hydrochloride, API in AntiHistamine therapy. This may be an added gain for Supriya Lifescience Ltd. Inside the European marketplace.
Global call for for Diphenhydramine Hydrochloride is 1850 heaps, of which principal call for is within the regulated markets.

News Updates